Frederico C. Xavier
Expertise in
5
conditions

Dr. Frederico C. Xavier

Pediatric Hematology Oncology
UPMC
Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
On Staff At
Offers Telehealth

Expertise in
5
conditions
UPMC
Pediatric Hematology Oncology In Lawrenceville
4401 Penn Avenue, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology. Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis. He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health. Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection. View the full list of Dr. Xavier’s publications on PubMed.

Dr. Xavier is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD).

His clinical research consists of co-authoring 29 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatrics in IN
Board Certifications
American Board Of Pediatrics
American Board Of Pediatrics
Fellowships
Federal University of Sao Paulo
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Pediatric Hematology Oncology in Lawrenceville
4401 Penn Avenue, Pittsburgh, PA 15224
Call: 412-692-5055

Additional Areas of Focus

Dr. Xavier has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


5 Clinical Trials

Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other
Study Phase: Phase 3
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Prospective, Randomized, Crossover Trial Comparing Recombinant Von Willebrand Factor (rVWF) vs. Tranexamic Acid (TA) to Minimize Menorrhagia in Women With Von Willebrand Disease: The VWD Minimize Study
Enrollment Status: Terminated
Publish Date: July 01, 2024
Intervention Type: Drug
Study Drugs: Von Willebrand Factor, Tranexamic Acid
Study Phase: Phase 3
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Multicenter, Randomized Phase III Inhibitor Prevention Trial, Comparing Eloctate vs. Emicizumab to Prevent Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: April 11, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Phase III Multi-Center, Randomized, Controlled Inhibitor Eradication Trial, Comparing Eloctate Immune Tolerance Induction (ITI) Plus Emicizumab vs. Eloctate ITI Alone to Eradicate Inhibitor Formation in Severe Hemophilia A
Enrollment Status: Terminated
Publish Date: February 21, 2023
Intervention Type: Drug
Study Drugs: Eloctate ITI, Emicizumab
Study Phase: Phase 3
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Phase III INHIBIT Platform: Prevention Trial, Eloctate vs Emicizumab to Prevent Inhibitors; Eradication Trial: Eloctate Immune Tolerance (ITI) Plus Emicizumab vs vs Eloctate ITI Alone to Eradicate Inhibitors in Severe Hemophilia A
Enrollment Status: Withdrawn
Publish Date: August 20, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

29 Total Publications

Targeted Treatment With Alpelisib for Papillary Intralymphatic Angioendothelioma Associated With Somatic PIK3CA Mosaicism.
Targeted Treatment With Alpelisib for Papillary Intralymphatic Angioendothelioma Associated With Somatic PIK3CA Mosaicism.
Journal: Pediatric blood & cancer
Published: June 16, 2025
View All 29 Publications
Similar Doctors
Paul M. Szabolcs
Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. Paul M. Szabolcs
Pediatric Hematology Oncology
Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. Paul M. Szabolcs
Pediatric Hematology Oncology

BMT At Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances

Paul Szabolcs, MD, received his medical degree summa cum laude at the Semmelweis University School of Medicine in Budapest, Hungary. He completed his training in pediatrics at Bellevue Hospital/NYU Medical Center and subsequently trained in hematology/oncology at the Memorial Sloan Kettering Cancer Center/Cornell-NY Hospital Medical Center in New York City. He received postdoctoral laboratory training at the Memorial Sloan Kettering Cancer Center and at Rockefeller University in the Department of Physiology and Cellular Immunology. Dr. Szabolcs is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Systemic Sclerosis (SSc), Delayed Growth, Infantile Neutropenia, and Wildervanck Syndrome.

James Felker
Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. James Felker
Pediatric Hematology Oncology
Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. James Felker
Pediatric Hematology Oncology

Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

James Felker, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is assistant professor of medicine at the University of Pittsburgh School of Medicine. Dr. Felker received his medical degree from New York Medical College and completed his residency at Northwestern University/Ann & Robert H. Lurie Children’s Hospital of Chicago followed by a fellowship in pediatric hematology/oncology and neuro-oncology at Emory University/Children’s Healthcare of Atlanta, Ga. Dr. Felker’s clinical interests include pediatric brain and spinal tumors and clinical trial development. He has published numerous articles in peer-reviewed journals and is a member of the American Society of Pediatric Hematology/Oncology, American Society of Clinical Oncology, Society for Neuro-Oncology, Children’s Oncology Group, and the Pediatric Brain Tumor Consortium. His wife is a pediatric cardiologist at UPMC Children’s and has an interest in long term cardiac outcomes for oncology patients. Together they have two girls and a beagle mutt. Dr Felker enjoys running along the rivers in Pittsburgh while trying to avoid the hills. View the full list of Dr. Felker's publications on PubMed. View Dr. Felker's profile at the University of Pittsburgh School of Medicine – Department of Pediatrics. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Felker is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Brain Stem Cancer, Diffuse Midline Glioma H3 K27M-Mutant, Glioma, and Medulloblastoma.

Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. Steven W. Allen
Pediatric Hematology Oncology
Experienced in Immune Thrombocytopenic Purpura (ITP)
Dr. Steven W. Allen
Pediatric Hematology Oncology
4401 Penn Ave, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-7192
Languages Spoken:
English
See accepted insurances

Steven Allen is a Pediatric Hematologist Oncology provider in Pittsburgh, Pennsylvania. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Aplastic Anemia, Reticulohistiocytoma, Histiocytosis, and Rosai-Dorfman Disease.

VIEW MORE IMMUNE THROMBOCYTOPENIC PURPURA (ITP) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Xavier's expertise for a condition
ConditionClose
    • Distinguished
    • Hemophilia A
      Dr. Xavier is
      Distinguished
      . Learn about Hemophilia A.
      See more Hemophilia A experts
    • Hemophilic Arthropathy
      Dr. Xavier is
      Distinguished
      . Learn about Hemophilic Arthropathy.
      See more Hemophilic Arthropathy experts
    • Advanced
    • Blood Clots
      Dr. Xavier is
      Advanced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Hemophilia B
      Dr. Xavier is
      Advanced
      . Learn about Hemophilia B.
      See more Hemophilia B experts
    • Von Willebrand Disease (VWD)
      Dr. Xavier is
      Advanced
      . Learn about Von Willebrand Disease (VWD).
      See more Von Willebrand Disease (VWD) experts
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

        Patient Details

        This information is for the patient who will be seen at the appointment.

          Close

          Returning patient? Use your address on file with the provider.

          Insurance Details

          Please provide information of the primary insurance holder as the practice may require this information to schedule.

          Insurance Provider *
          Insurance ProviderClose

          Appointments Details

          Let’s get more information about your appointment.

                  0 / 1000
                  0 / 1000
                  By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.